Dave Hava
@davehava.bsky.social
Chief Scientific Officer at Alltrna. Former CSO at Synlogic, Metera Pharmaceuticals and Pulmatrix. Microbiologist, immunologist and drug developer. Opinions are my own.
Thrilled to join @alltrna.bsky.social as CSO. In my career I’ve focused on turning bold platform science into first-in-class therapies, and I look forward to working with this extraordinary team on this once-in-a-generation opportunity to redefine genetic medicine for rare and underserved diseases.
Alltrna appoints Dave Hava as CSO. With two decades translating breakthrough science into first-in-class drugs, he will expand and prioritize our tRNA medicines pipeline. Grateful to our first CSO Chris Henderson, who will continue to guide our science as our SAB chair.
bit.ly/4mPxcbK
bit.ly/4mPxcbK
September 3, 2025 at 3:43 PM
Thrilled to join @alltrna.bsky.social as CSO. In my career I’ve focused on turning bold platform science into first-in-class therapies, and I look forward to working with this extraordinary team on this once-in-a-generation opportunity to redefine genetic medicine for rare and underserved diseases.
This is a fantastic program and one that provided some great and talented people to work with at Synlogic
The Gloucester Biotechnology Academy's program gives students free hands-on STEM training and a lab internship.
Ask Alexa to play WBZ NewsRadio on #iHeartRadio.
wbznewsradio.iheart.com/content/glou...
Ask Alexa to play WBZ NewsRadio on #iHeartRadio.
wbznewsradio.iheart.com/content/glou...
Gloucester Biotech Academy Accepting Applications For Free STEM Training | WBZ NewsRadio 1030
The Gloucester Biotechnology Academy's program gives students free hands-on STEM training and a lab internship.
wbznewsradio.iheart.com
December 4, 2024 at 7:59 PM
This is a fantastic program and one that provided some great and talented people to work with at Synlogic
Reposted by Dave Hava
I’m creating a drug development starter pack, reach out to join or suggest additions: go.bsky.app/B2pzQm2
November 10, 2024 at 6:50 PM
I’m creating a drug development starter pack, reach out to join or suggest additions: go.bsky.app/B2pzQm2
This was a great work by the Synlogic and Ginkgo teams.
Sharing a closer look at how we helped Synlogic develop a new drug candidate for the treatment of Homocystinuria in less than a year:
www.ginkgobioworks.com/2023/10/19/s...
www.ginkgobioworks.com/2023/10/19/s...
Synlogic Leverages Ginkgo’s Cell Engineering Platform to Develop Potential New Treatment for Homoc...
Within a year, Ginkgo’s collaboration with Synlogic resulted in the naming of the investigational new drug, SYNB1353.
www.ginkgobioworks.com
December 7, 2023 at 3:06 PM
This was a great work by the Synlogic and Ginkgo teams.